GoldenGolden
Advanced Search
Senti Biosciences

Senti Biosciences

Senti Biosciences is a synthetic biology company.

Senti Biosciences is a synthetic biology company headquartered in South San Francisco, California, and was founded in 2016 by Jim Collins, Philip Lee, Tim Lu, and Wilson Wong. Senti Biosciences has a proprietary synthetic biology platform for the development of therapeutics. The company uses genetic circuits to program cell therapies so that they have localized action, sensors, dynamic responses, and safety control.

Timeline

January 2021
Senti Biosciences raises a $105,000,000 series B round from 8VC, Amgen Ventures, Intel Capital, Intel Capital Diversity Fund, Leaps by Bayer, Lux Capital, Matrix Partners China III, L.P., Mirae Asset Capital and Ridgeback Capital.
2016
Senti Biosciences was founded by Jim Collins, Philip Lee, Timothy Lu and Wilson Wong.

Funding rounds

People

Name
Role
LinkedIn

Gary Lee, Ph.D.​

Chief Scientific Officer

Philip Lee, Ph.D.

Co-Founder, COO

Curt Herberts, M.B.S.

Chief Financial Officer and Chief Business Officer

Jim Collins, Ph.D.

Scientific Co-Founder

Tim Lu, M.D., Ph.D.

Co-Founder, CEO

Wilson Wong, Ph.D.

Scientific Co-Founder

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.